These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 23774156)
1. Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey. Tlougan BE; Lee MT; Drolet BA; Frieden IJ; Adams DM; Garzon MC J Pediatr Hematol Oncol; 2013 Nov; 35(8):618-22. PubMed ID: 23774156 [TBL] [Abstract][Full Text] [Related]
2. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Chiu YE; Drolet BA; Blei F; Carcao M; Fangusaro J; Kelly ME; Krol A; Lofgren S; Mancini AJ; Metry DW; Recht M; Silverman RA; Tom WL; Pope E Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Corticosteroid and Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma: A Systematic Review and Meta-Analysis. Yao W; Li K; Wang Z; Pei J; Liu X; Zheng S; Dong K Eur J Pediatr Surg; 2019 Oct; 29(5):401-407. PubMed ID: 30372769 [TBL] [Abstract][Full Text] [Related]
4. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up. Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262 [TBL] [Abstract][Full Text] [Related]
6. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Wang Z; Li K; Dong K; Xiao X; Zheng S Pediatr Blood Cancer; 2014 Aug; 61(8):1518-9. PubMed ID: 24482015 [No Abstract] [Full Text] [Related]
7. Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma. Liu X; Li J; Qu X; Yan W; Zhang L; Zhang S; Yang C; Zheng J Medicine (Baltimore); 2016 May; 95(20):e3431. PubMed ID: 27196448 [TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy and safety of corticosteroid and vincristine in treating kaposiform hemangioendothelioma and tufted angioma: A multicenter prospective randomized controlled clinical trial. Yao W; Li K; Wang Z; Wang J; Ji Y; Zhou L; Huang H; Gao X; Huang Z; Gu S; Yang H; Zheng S J Dermatol; 2021 May; 48(5):576-584. PubMed ID: 33608936 [TBL] [Abstract][Full Text] [Related]
9. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma. Wang H; Guo X; Duan Y; Zheng B; Gao Y Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213 [TBL] [Abstract][Full Text] [Related]
10. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy. Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642 [TBL] [Abstract][Full Text] [Related]
11. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence? Ji Y; Chen S; Yang K; Xia C; Peng S J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment of Kaposiform hemangioendothelioma with everolimus. Uno T; Ito S; Nakazawa A; Miyazaki O; Mori T; Terashima K Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933 [TBL] [Abstract][Full Text] [Related]
13. Treatment of kaposiform hemangioendothelioma and tufted angioma. Liu XH; Li JY; Qu XH; Yan WL; Zhang L; Yang C; Zheng JW Int J Cancer; 2016 Oct; 139(7):1658-66. PubMed ID: 27252149 [TBL] [Abstract][Full Text] [Related]
14. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus. Cashell J; Smink GM; Helm K; Xavier F Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028 [TBL] [Abstract][Full Text] [Related]
15. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon. Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627 [No Abstract] [Full Text] [Related]
16. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES. Benzar IM; Rebenkov SO; Levytskyi AF; Fedoniuk LY; Fomina LV; Sas LM; Stravskyy TY Wiad Lek; 2020; 73(8):1785-1789. PubMed ID: 33055352 [TBL] [Abstract][Full Text] [Related]
17. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma. Zhang X; Yang K; Chen S; Ji Y J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046 [TBL] [Abstract][Full Text] [Related]
18. Ultrasonography and magnetic resonance imaging features of kaposiform hemangioendothelioma and tufted angioma. Gong X; Ying H; Zhang Z; Wang L; Li J; Ding A; Zhou L; Lin X; Xiong P J Dermatol; 2019 Oct; 46(10):835-842. PubMed ID: 31373042 [TBL] [Abstract][Full Text] [Related]
19. Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions. Duan L; Renzi S; Weidman D; Waespe N; Chami R; Manson D; Cada M; Carcao M J Pediatr Hematol Oncol; 2020 Jan; 42(1):74-78. PubMed ID: 30044355 [TBL] [Abstract][Full Text] [Related]
20. Anesthestic management of Kassabach-Meritt Phenomenon in an adult: case report. Elkoundi A; Samali M; Kartite N; Tbouda M; Bensghir M; Haimeur C BMC Anesthesiol; 2016 Nov; 16(1):109. PubMed ID: 27829366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]